Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Submitting Your Manuscript
The goal of Tissue Engineering is to inform its readers of significant developments in areas related to tissue engineering. Tissue Engineering Methods (Part C) presents innovative tools and assays in scaffold development, stem cells, and biologically active molecules to advance the field and to support clinical translation. The journal publishes methods and protocols in life and natural sciences relevant to tissue engineering and regenerative medicine. A method manuscript involves a novel research method that has not been published before. A protocol manuscript deals with a method that has already been used successfully in a wide range of experiments.
In order to help defray the costs of processing, the Journal requires a nonrefundable, per-manuscript submission fee of $95.00 USD regardless of final editorial decision.
The submitting author is required to complete the submission using an ORCID identifier. Please visit the ORCID website for more information, or to register. You must have an account in ScholarOne for Tissue Engineering, Parts A, B, & C before logging in with an ORCID identifier.
Manuscript Submission Site
Create an Account in ScholarOne
If you do not already have an account in ScholarOne for Tissue Engineering, Parts A, B, & C, you will need to create one. Once you create your account, you may log in to the system to begin your submission. Each listed author on a submission must either have an account, or have one created, in the submission system.
See JOURNAL STANDARDS AND BEST PRACTICES STATEMENT
Check the Journal’s PEER REVIEW POLICIES
The ultimate decision regarding the assignment of manuscripts is left to the discretion of the Editors-in-Chief. At any time prior to publication, the Editors of Tissue Engineering may reassign an article from one Part of Tissue Engineering to another. Language must conform to acceptable English usage and syntax. The contents must be clear, accurate, coherent, and logical. In accepting, rejecting or reassigning a manuscript to another Part of the journal, the editors will also consider its originality, teaching value, and validity.
Decisions concerning journal assignment, editing, revisions, acceptances, and rejections will be made by the editors. These may include reassigning an article from one Part of Tissue Engineering to another, shortening the article, reducing the number of figures and tables, or changing the format. An accepted article may be published with an accompanying discussion if the editors so desire.
For further information about editorial questions on manuscripts in the online peer-review process, please contact TEeditor@rice.edu
For technical information on using ScholarOne, contact AuthorServices@liebertpub.com
(See AUTHORSHIP DEFINITION AND RESPONSIBILITIES)
All authors, including the co-authors, should be responsible for a significant part of the manuscript. All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content. Any author whose name appears on a manuscript assumes responsibility and accountability for the results.
All Original submissions must contain:
- An Institutional Review Board (IRB) approval (or waiver) statement in the Methods section
- Acknowledgments section (if applicable) after the Conclusion of the paper, followed by
- An Author Contribution statement for each listed author, followed by
- An Author Disclosure Statement for each author listed on a submission, even if there are no conflicts to disclose, followed by,
- Funding statement(s), even if there is no funding information to declare.
All manuscripts must be prepared in accordance with the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations).
When submitting your manuscript for peer review, be prepared to:
- Enter the full title of the manuscript
- Enter the full names and institutional affiliations of ALL listed authors
- Enter ALL listed authors' institutional email addresses
- Identify the corresponding author
- Enter a running (abbreviated) title of no more than 50 characters (including spaces).
- Enter 3–6 keywords or phrases.
- Provide an unstructured abstract of 100-350 words consisting of factual information and not generalities (the problem investigated, the method used, and experimental data obtained).
- Provide the names and email addresses of at least five potential preferred reviewers familiar with the field. Please make sure preferred reviewers are not from your university or institution or with whom you have collaborated. Anyone whom the author does not want to be considered should also be named as a non-preferred reviewer. Ultimate reviewer selection is at the Editor’s discretion.
- Confirm that the material has not been published or submitted for publication elsewhere
During the submission process, you will be asked to provide an Impact Statement of 100 words or less describing the importance of the presented research and its potential effect on the field. This text must be included within the main text file, immediately following the abstract.
Create an Effective Title
- Manuscript titles should be brief, contain key terms, and clearly identify the purpose
- of the work conducted
- Manuscript titles should not exceed 15 -18 words. Exceptions can be made with the Editor’s approval
- Manuscript titles should be direct and to the point. Remember that the journal has a global readership, so clear and concise non-vernacular language is most effective
- Avoid the use of specific locations in the title
- Do not use proprietary/trademarked names in the title
- Do not use acronyms in the title unless they are universally recognized and accepted
- NOTE: The title page of your submission must be included as part of your main text document (not as a separate file).
All file names should be in English and contain only alphanumeric characters. Do not include spaces, symbols, special characters, dashes, dots, or underscores. Label each file with the first author's last name, followed by the content of the file (i.e.: SmithText; SmithTables; SmithFigureLegends; SmithFig1, etc.)
Important: Please upload individual files of all manuscript material as described herein — please do NOT upload a combined PDF file containing all material in your submission.
Preparation of Manuscript
Prepare text of manuscripts, figure legends, and tables in Microsoft Word, double spaced. The order of elements in each manuscript should be:
- Title page (with full manuscript title, all contributing authors’ names, degrees, and their affiliations [where the work was performed], a short running title, a denotation of the corresponding author, and a list of 3-6 keywords). We require the full mailing address and contact information (telephone and e-mail address for EACH author).
- Impact statement
- Main text (do not embed figures or tables)
- Conclusion (as a separate paragraph, not as part of the Discussion section)
- Acknowledgments (if applicable)
- Authorship confirmation statement (see below)
- Author(s’) disclosure statement(s) (see below)
- Funding statement (see below)
- Figure legends
- Supplemental files (if applicable. If the submission is accepted, Supplemental Information will NOT be published in the Just Accepted/LION platform, but instead will be published in the Online Now (epub) and final versions of the article. Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.)
Maximum word count for manuscripts should not exceed 4,000 words. In general, the text should be organized under the headings: Introduction, Method, Experiment, and Discussion. A brief introduction should state the research problem, explain/define why a new method or protocol had to be developed, and justify the need for the new method or protocol with literature references. The method section should explain the methodological approach in a coherent way. In a protocol manuscript, the method section should provide clear instructions for all steps that have to be taken to perform the procedure. It is essential that as much information is provided to allow the reader to use the method or protocol for their own experiment. Furthermore, an accurate list must be provided of all essential equipment, facilities, materials, reagents, etc. that are used.
The method section must be followed by a section titled “Experiment”. This section should provide a description of an experiment in which the method or protocol was used. Care has to be taken that the suitability of the method or protocol is indeed substantiated with experimental data. Depending on the method, controls have to be included in this experiment. For a protocol manuscript, reference has to be made to earlier publications of the author(s), in which the respective protocol was already used successfully.
In the discussion section, additional background information should be provided. How the method or protocol compares with other methods and protocols should be discussed and additional information provided about the possible wider application of the method or protocol. Pitfalls and problems that can be encountered should also be addressed in this section.
Use only standard abbreviations, which can be found in the AMA’s Manual of Style for Authors and Editors, 10th edition or the Council of Science Editors (CSE) Style Manual, 8th edition. At first usage, spell out terms and provide abbreviations in parentheses. Thereafter, use only the abbreviations. It is not necessary to spell out standard units of measure. Use generic names for drugs if possible. If you wish to use a proprietary drug name the first time it appears, use the generic name followed by the proprietary name, manufacturer, and location in parentheses.
If a statistical analysis is done, an explanation of how it was performed must be stated at the end of the section preceding the results. Unusual or complex methods of analysis should be referenced.
References must be prepared in Word, double spaced, and numbered consecutively as they are cited in the text (using superscript numbers). Include the reference section as part of the main text file, not as a separate file. References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. Use journal abbreviations as provided by PubMed/Medline. List all authors when there are six or fewer. When there are more than six authors, list the first three, followed by et al. (not italicized). If references to personal communications or unpublished data are used, they are not to be in the list of references. They should be referred to in the text in parentheses: (AB Jones, personal communication). Include among the references any articles that have been accepted but have not yet published; identify the name of publication and add "In Press." If the reference has been published online, provide the DOI number in place of the page range.
Sample style for references:
Patel JM, Wise BC, Bonnevie ED, Mauck RL. A systematic review and guide to mechanical testing for articular cartilage tissue engineering. Tissue Eng Part C Methods 2019;25:593-608.
Volume and edition numbers, and the name of the translator should be included when appropriate.
Al’Aref SJ, Mosadegh B, Dunham S, Min JK, eds. 3D Printing Applications in Cardiovascular Medicine. Cambridge, MA: Academic Press, an imprint of Elsevier; 2018.
Chapter in a book:
Jung B, Theato P. Chemical strategies for the synthesis of protein–polymer conjugates. In: Schlaad H, ed. Bio-Synthetic Polymer Conjugates. Advances in Polymer Science, Vol. 253. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2012, pp. 37-70.
Krauss EM, Moore AM, Agenor A, Mackinnon SE. Short-term outcomes of the nerve “dwindling” procedure using long processed nerve allograft in recurrent lower extremity neuroma. Abstract presented at the American Society for Peripheral Nerve Annual Meeting, Scottsdale, AZ, 2016. Abstract no. 38.
Figure legends should be uploaded as a separate Word file and double spaced. In the legend, provide explanations for any abbreviations, arrows, etc. that appear in the figure. Legends for photomicrographs should identify the stain and state the magnification. If the illustration is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section. The copyright holder’s letter of permission should be submitted to Tissue Engineering upon submission.
All tables should be prepared in one single Word file. Provide a title for each table. Cite tables in sequence in the text. Explain abbreviations used in the body of the table in footnotes. If the table is taken from a copyrighted publication, permission must be secured, appropriate credit must be given in the legend, and a corresponding reference must appear in the reference section. The copyright holder’s letter of permission should be submitted to Tissue Engineering upon submission.
- Submission of high resolution .TIFF or .EPS figure files is strongly recommended.
- Figures should not be embedded within the manuscript file.
- Cite figures consecutively in text within parentheses.
- A legend should be supplied for each figure and all legends numbered consecutively.
- Images should not show the name of a patient or a manufacturer.
- Do not include any illustrations as part of your text file.
Because of space limitations, the authors should be frugal with their illustrations. Occasional exceptions will be made for prize-winning essays, collective reviews, solicited material, or special works.
Authors are encouraged to submit outstanding color photographs for possible use as cover art. Photos should be submitted in two sizes: 8½ x 11'' or slightly larger for the cover, and at the size it will appear at in the published article. For further information about submitting cover art, please contact the Editorial Office.
Following the references, provide the name and complete affiliation and institutional email address of the person to whom correspondence should be sent.
To upload a revision of a manuscript, the submitting author should log in to their Author Center and click on “Revised Manuscripts in Draft.” All revised submissions will be required to meet all formatting conditions described herein. Submissions that do not satisfy these requirements will be un-submitted and returned to the submitting author for proper configuration.
Journal Policies on:
Licensing Information: OPEN ACCESS and Copyright
Data Sharing and Preprint Policies
Post-Acceptance and Post-Publication Policies
Correction Statements / Retractions
Reprints, Permissions, & Social Media Use
Plagiarism Detection Software
Definitions of Scientific Misconduct
Responding to Allegations of Scientific Misconduct
Press Embargo Policy
Archiving and Preservation
For questions regarding manuscript submissions, contact our Author Services Division. AuthorServices@liebertpub.com
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.